Accessibility Menu
 
BioArctic Ab (publ) logo

BioArctic Ab (publ)

(OTC) BRCTF

Current Price$33.02
Market Cap$2.93B
Since IPO (2022)+25%
5 YearN/A
1 Year+59%
1 Month-13%

BioArctic Ab (publ) Financials at a Glance

Market Cap

$2.93B

Revenue (TTM)

$2.00B

Net Income (TTM)

$1.02B

EPS (TTM)

$1.08

P/E Ratio

30.55

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$33.02

Volume

15

Open

$33.02

Previous Close

$33.02

Daily Range

$33.02 - $33.02

52-Week Range

$15.49 - $40.00

BRCTF News

BRCTF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BioArctic Ab (publ)

Industry

Biotechnology

Employees

131

CEO

Gunilla Christina Osswald, PhD

Headquarters

Stockholm, 112 51, SE

BRCTF Financials

Key Financial Metrics (TTM)

Gross Margin

97%

Operating Margin

63%

Net Income Margin

51%

Return on Equity

65%

Return on Capital

61%

Return on Assets

40%

Earnings Yield

3.27%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.93B

Shares Outstanding

88.64M

Volume

15

Short Interest

0.00%

Avg. Volume

33.656

Financials (TTM)

Gross Profit

$1.94B

Operating Income

$1.36B

EBITDA

$1.38B

Operating Cash Flow

$1.43B

Capital Expenditure

$1.43B

Free Cash Flow

$0.00

Cash & ST Invst.

$2.18B

Total Debt

$72.24M

BioArctic Ab (publ) Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$183.57M

+81.3%

Gross Profit

$168.55M

+88.6%

Gross Margin

91.82%

N/A

Market Cap

$2.93B

N/A

Market Cap/Employee

$27.35M

N/A

Employees

107

N/A

Net Income

$8.81M

+72.0%

EBITDA

$37.74M

+187.3%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$2.11B

+360.6%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$56.55M

+37.7%

Short Term Debt

$15.68M

+19.3%

Return on Assets

39.70%

N/A

Return on Invested Capital

61.34%

N/A

Free Cash Flow

$0.00

+100.0%

Operating Cash Flow

$312.54M

+1242.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GENSFGenus plc
$35.97+0.00%
DMPHFDermapharm Holding SE
$39.56+0.00%
MEOBFMesoblast Limited
$1.60+18.52%
HTSUFHisamitsu Pharmaceutical Co., Inc.
$29.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%
ARTLArtelo Biosciences
$10.54+2.30%

Questions About BRCTF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.